Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

1 High-Flying Stock to Buy Hand Over Fist if the Stock Market Crashes

Key Points Moderna’s personalized cancer vaccine candidate, intismeran autogene, significantly reduced the risk of melanoma recurrence in a Phase 3 trial, a first for a personalized cancer vaccine.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at nasdaq.com →

More in Finance & Markets

More from Friday 20 November →